Ilse Wiechers, MD, MPP, MHS

  • 3Articles
  • 20.7KReads
  • 2021–2024Active
  • 19Collaborators
  • 43Citations

About

Ilse Wiechers, MD, MPP, MHS, is affiliated with the Office of Mental Health at the Veterans Health Administration in Washington, DC, and the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco School of Medicine. Between 2021 and 2024, Wiechers published research on veterans and military issues, focusing on posttraumatic stress disorder and treatment-resistant depression. The work includes studies on treatment algorithms, medication prescribing trends in PTSD, and approaches to difficult-to-treat depression within the Veterans Health Administration. Frequent collaborators include Ana-Marie Urbieta, Anne Woods, Annie Ryder, Beth E. Cohen, and David C. Mohr.

Publications

JCP
Difficult to Treat Depression: Focus on Approach, Algorithms, and Access
Academic Highlights

Difficult to Treat Depression: Focus on Approach, Algorithms, and Access

November 25, 2024

The Southwest Forum on Difficult to Treat Depression brought together 11 experts to discuss aspects of managing difficult-to-treat depression. This article presents highlights from the forum, covering such topics...
, , , et al
JCP
Algorithms for TRD Treatment Success
Insights

Algorithms for TRD Treatment Success

July 12, 2024

Ilse Wiechers presents an in-depth exploration of advanced neuromodulation techniques for treating difficult-to-treat depression. Discover cutting-edge research, clinical applications, and the latest insights on personalized brain stimulation approaches aimed...
JCP
Original Research

PTSD Medication Prescribing Trends From 2009 to 2018

May 4, 2021

Although psychotherapy is available via the Veterans Health Administration, most veterans diagnosed with posttraumatic stress disorder (PTSD) receive pharmacotherapy. This study evaluated longitudinal prescription practice trends for veterans with...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe